BioNTech SE is 15.7x more valuable than NOVAVAX INC by market capitalization ($22.90 B vs $1.46 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVAX | BNTX |
|---|---|---|
| Market cap | $1.46 B | $22.90 B |
| US-listed rank | #2365 | #572 |
| Revenue (latest FY) | $1.12B | - |
| Net income (latest FY) | $440.30M | - |
| Net margin | 39.2% | - |
| P/E (trailing FY) | 3.3 | - |
| SEC filings | 1,627 | 548 |
BioNTech SE is 15.7x more valuable than NOVAVAX INC by market capitalization ($22.90 B vs $1.46 B).
Full pages: NOVAVAX INC and BioNTech SE, or browse the full rankings.